Mitsubishi Tanabe Pharma Corporation

03/28/2019 | Press release | Distributed by Public on 03/27/2019 22:45

The Global Health Innovative Technology Fund provides grant for joint research into anti-malarial drugs conducted by Mitsubishi Tanabe Pharma and a malaria research institution